Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Holz, F. G. (2020). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology (Rochester, Minn.), 127(1), 72. https://doi.org/10.1016/j.ophtha.2019.04.017
Citace podle Chicago (17th ed.)Dugel, Pravin U., et al. "HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration." Ophthalmology (Rochester, Minn.) 127, no. 1 (2020): 72. https://doi.org/10.1016/j.ophtha.2019.04.017.
Citace podle MLA (9th ed.)Dugel, Pravin U., et al. "HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration." Ophthalmology (Rochester, Minn.), vol. 127, no. 1, 2020, p. 72, https://doi.org/10.1016/j.ophtha.2019.04.017.